Two foreign vaccine firms hit by administrative dispositions

Published: 2004-11-25 06:59:00

Updated: 2004-11-25 06:59:00

The Korea Food and Drug Administration announced on November 23 that it meted out a certain amount of fines (corresponding to sales ban for fourth months) to two foreign-invested pharmaceutical firms each for falsely advertising their vaccine products, GlaxoSmithKline (GSK) and Aventis Pasteur Ko...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK